Influence of Ambulatory Triglyceride Levels on Risk of Recurrence in Patients with Hypertriglyceridemic Pancreatitis
Sign Up to like & getrecommendations! Published in 2018 at "Digestive Diseases and Sciences"
DOI: 10.1007/s10620-018-5226-x
Abstract: Background and AimsTo evaluate impact of ambulatory triglyceride levels on risk of recurrent pancreatitis in patients with hypertriglyceridemic pancreatitis.MethodsWe conducted a longitudinal retrospective cohort study of patients with serum triglyceride level ≥ 500 mg/dL during index hospitalization… read more here.
Keywords: patients hypertriglyceridemic; hypertriglyceridemic pancreatitis; ambulatory triglyceride; triglyceride levels ... See more keywords
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Sign Up to like & getrecommendations! Published in 2022 at "Nature Reviews Cardiology"
DOI: 10.1038/s41569-022-00676-y
Abstract: Accumulating evidence points to the causal role of triglyceride-rich lipoproteins and their cholesterol-enriched remnants in atherogenesis. Genetic studies in particular have not only revealed a relationship between plasma triglyceride levels and the risk of atherosclerotic… read more here.
Keywords: plasma triglyceride; triglyceride rich; disease; triglyceride ... See more keywords
Plasma reduction of apolipoprotein C-III with olezarsen leads to significant reductions in postprandial triglyceride levels: Results from a randomized trial.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwaf478
Abstract: BACKGROUND Hypertriglyceridemia is an established risk factor for cardiovascular disease and acute pancreatitis with postprandial elevations as an important contributor. Olezarsen, an investigational antisense oligonucleotide targeting plasma apolipoprotein C-III (apoC-III), markedly reduces fasting triglyceride levels,… read more here.
Keywords: postprandial triglyceride; trial; triglyceride levels; reduction ... See more keywords
Is hypertriglyceridemia atherogenic?
Sign Up to like & getrecommendations! Published in 2019 at "Current Opinion in Lipidology"
DOI: 10.1097/mol.0000000000000622
Abstract: PURPOSE OF REVIEW Hypertriglyceridemia occurs mainly because of metabolic disorders secondary to diabetes, alcohol intake, and/or overweight. Genetic factors have also been clearly identified in most severe cases. Triglycerides are generally considered as 'bystanders' for… read more here.
Keywords: triglyceride; biology; hypertriglyceridemia; hypertriglyceridemia atherogenic ... See more keywords
Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment
Sign Up to like & getrecommendations! Published in 2019 at "Arteriosclerosis, Thrombosis, and Vascular Biology"
DOI: 10.1161/atvbaha.119.312336
Abstract: Objective— Secondary prevention for recurrent myocardial infarction (MI) is one of the most important therapeutic goals in patients with old MI (OMI). Although statins are widely used for this purpose, there remains considerable residual risk… read more here.
Keywords: lipoprotein cholesterol; residual risks; triglyceride; density lipoprotein ... See more keywords
Abstract 4139852: Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data From Subjects in an Open-Label Extension Trial
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4139852
Abstract: Despite current modestly effective triglyceride (TG) lowering therapies, the availability of more effective agents for persistently lowering elevated TGs and risk of acute pancreatitis remains a continuing need. More recently identified triglyceride-rich lipoproteins (TRLs), specifically… read more here.
Keywords: long term; plozasiran; extension; triglyceride ... See more keywords
Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction
Sign Up to like & getrecommendations! Published in 2018 at "PLoS ONE"
DOI: 10.1371/journal.pone.0205006
Abstract: Fibrates are used in patients with dyslipidemia and high cardiovascular risk. However, information regarding drug response to fibrate has been highly limited. We investigated treatment results and factors associated with triglyceride reduction after fenofibrate therapy… read more here.
Keywords: reduction; real world; factors associated; triglyceride levels ... See more keywords
Reduced Reverse Cholesterol Transport Efficacy in Healthy Men with Undesirable Postprandial Triglyceride Response
Sign Up to like & getrecommendations! Published in 2020 at "Biomolecules"
DOI: 10.3390/biom10050810
Abstract: Elevation of nonfasting triglyceride (TG) levels above 1.8 g/L (2 mmol/L) is associated with increased risk of cardiovascular diseases. Exacerbated postprandial hypertriglyceridemia (PP–HTG) and metabolic context both modulate the overall efficacy of the reverse cholesterol… read more here.
Keywords: reverse cholesterol; response; efficacy; triglyceride ... See more keywords
Effect of Maternal Glucose and Triglyceride Levels during Early Pregnancy on Pregnancy Outcomes: A Retrospective Cohort Study
Sign Up to like & getrecommendations! Published in 2022 at "Nutrients"
DOI: 10.3390/nu14163295
Abstract: Maternal dysglycemia and lipid metabolic dysfunction have been recognized as risk factors for pregnancy complications and adverse perinatal outcome jointly and separately, but current diagnostic window-period which is at the end of the second trimester… read more here.
Keywords: early pregnancy; pregnancy outcomes; retrospective cohort; pregnancy ... See more keywords